Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Cash from Investing Activities (2018 - 2025)

Exagen (XGN) has disclosed Cash from Investing Activities for 8 consecutive years, with -$35000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 76.03% year-over-year to -$35000.0, compared with a TTM value of -$626000.0 through Dec 2025, down 21.55%, and an annual FY2025 reading of -$626000.0, down 21.55% over the prior year.
  • Cash from Investing Activities was -$35000.0 for Q4 2025 at Exagen, up from -$275000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$2000.0 in Q3 2023 and bottomed at -$1.9 million in Q2 2022.
  • Average Cash from Investing Activities over 5 years is -$434150.0, with a median of -$242000.0 recorded in 2025.
  • The sharpest move saw Cash from Investing Activities plummeted 21180.0% in 2021, then soared 99.77% in 2023.
  • Year by year, Cash from Investing Activities stood at -$1.1 million in 2021, then soared by 61.84% to -$406000.0 in 2022, then surged by 79.31% to -$84000.0 in 2023, then plummeted by 73.81% to -$146000.0 in 2024, then soared by 76.03% to -$35000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for XGN at -$35000.0 in Q4 2025, -$275000.0 in Q3 2025, and -$209000.0 in Q2 2025.